Scarica l'app Stockscreener
8.36
0.00%
0.00
Pre-mercato:
9.80
1.44
+17.22%
Precedente Chiudi:
$8.36
Aprire:
$8.5
Volume 24 ore:
97,504
Relative Volume:
0.66
Capitalizzazione di mercato:
$2.51B
Reddito:
$391.87M
Utile/perdita netta:
$-441.45M
Rapporto P/E:
-4.5189
EPS:
-1.85
Flusso di cassa netto:
$-301.21M
1 W Prestazione:
+0.48%
1M Prestazione:
-27.74%
6M Prestazione:
-35.19%
1 anno Prestazione:
-37.61%
Intervallo 1D:
$8.34
$8.75
Intervallo di 1 settimana:
$8.04
$8.75
Portata 52W:
$7.35
$14.76
Alvotech Stock (ALVO) Company Profile
Confronta ALVO con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ALVO
Alvotech
|
8.36 | 2.51B | 391.87M | -441.45M | -301.21M | -1.85 |
|
ZTS
Zoetis Inc
|
150.91 | 65.46B | 9.26B | 2.49B | 2.30B | 5.47 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.18 | 46.11B | 30.25B | 1.37B | 5.08B | 0.4257 |
|
HLN
Haleon Plc Adr
|
10.23 | 45.84B | 14.35B | 1.85B | 0 | 0.4023 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
14.29 | 16.37B | 16.54B | -1.64B | 749.00M | -1.45 |
|
UTHR
United Therapeutics Corp
|
293.46 | 12.81B | 2.76B | 1.11B | 898.10M | 22.77 |
Alvotech Stock (ALVO) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-02-14 | Iniziato | UBS | Buy |
| 2024-01-29 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2023-10-20 | Aggiornamento | Citigroup | Sell → Neutral |
| 2023-09-21 | Iniziato | Barclays | Equal Weight |
| 2022-09-07 | Iniziato | Morgan Stanley | Equal-Weight |
| 2022-09-06 | Downgrade | Citigroup | Buy → Sell |
| 2022-07-26 | Iniziato | Citigroup | Buy |
Mostra tutto
Alvotech Borsa (ALVO) Ultime notizie
Legal & General Group Plc Decreases Position in Alvotech (NASDAQ:ALVO) - MarketBeat
Xbrane Approves Deal Giving Away Cimzia Rival To Alvotech - insights.citeline.com
FY2025 EPS Estimates for Alvotech Cut by Northland Capmk - MarketBeat
Alvotech (NASDAQ:ALVO) Sets New 52-Week LowHere's Why - MarketBeat
Alvotech (NASDAQ:ALVO) Stock Price Down 6.9%What's Next? - MarketBeat
Announcement from extra general meeting in Xbrane Biopharma AB - TradingView
Benign Growth For Alvotech (NASDAQ:ALVO) Underpins Stock's 25% Plummet - simplywall.st
Alvotech (NASDAQ:ALVO) Trading Down 3.5%Should You Sell? - MarketBeat
Major Drug Launch: Teva's New Stelara Biosimilar Targets Multiple Billion-Dollar Markets - Stock Titan
Alvotech (NASDAQ:ALVO) Sets New 12-Month LowShould You Sell? - MarketBeat
Alvotech stock hits 52-week low at $8.88 amid market challenges - Investing.com Canada
Alvotech stock hits 52-week low at $8.88 amid market challenges By Investing.com - Investing.com South Africa
The Escalator: HHS, Spectrum Science, Alvotech and more - Medical Marketing and Media
Oaktree Capital Management LP Lowers Holdings in Alvotech (NASDAQ:ALVO) - MarketBeat
Who’s Hired? Alvotech Appoints Strategy And Quality Chiefs - insights.citeline.com
Biosimilars Help Alvotech Revenues Soar Over 400% Year Over Year - Center for Biosimilars®
Alvotech (NASDAQ:ALVO) Trading Down 7.6%Should You Sell? - MarketBeat
Alvotech (NASDAQ:ALVO) Posts Earnings Results, Beats Expectations By $0.50 EPS - MarketBeat
Alvotech (NASDAQ:ALVO) Just Reported And Analysts Have Been Lifting Their Price Targets - Yahoo Finance
Earnings call transcript: Alvotech’s Q4 2024 results show revenue surge By Investing.com - Investing.com Australia
Aurion names Arnaud Lacoste CEO - BioCentury
Alvotech Reveals Ramp-Up In Development As Sales Explode In 2024 - insights.citeline.com
Alvotech Full Year 2024 Earnings: Revenues Beat Expectations, EPS Lags - simplywall.st
ALVO Latest Report - AInvest
Alvotech Achieves Record Revenue Growth in 2024 - TipRanks
Earnings call transcript: Alvotech’s Q4 2024 results show revenue surge - Investing.com India
Trump Must Be ‘Harsh’ With Big Pharma, Says Icelandic Drugmaker - Bloomberg.com
Alvotech Appoints Dr. Balaji V. Prasad As Chief Strategy Officer - MarketScreener
Alvotech Appoints New Chief Strategy Officer to Strengthen Market Position - TipRanks
Alvotech Achieves Record 2024 Financial Results and Expands Biosimilar Pipeline - TipRanks
Iceland's Alvotech Appoints Chief Strategy Officer - MarketScreener
Alvotech Appoints Dr. Balaji V. Prasad as Chief Strategy Officer - The Manila Times
Alvotech earnings missed by $0.04, revenue topped estimates - Investing.com Australia
Alvotech SA reports results for the quarter ended December 31Earnings Summary - TradingView
Alvotech earnings missed by $0.04, revenue topped estimates By Investing.com - Investing.com South Africa
Alvotech : Press Release Full Year 2024 - MarketScreener
Alvotech Reports Record Results for 2024 and Provides Business Update - The Manila Times
Deal Watch: Eyenovia Looks At New Direction In Proposed Merger With Betaliq - insights.citeline.com
Alvotech Azioni (ALVO) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.57%
0.15%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):